8-KEarnings & ResultsMaterial AgreementsRegulation FD+1

INTUITIVE SURGICAL INC 8-K Report, Material Agreement (Jan 24, 2017)

Filed January 24, 2017For Securities:ISRG

Summary

Intuitive Surgical, Inc. (ISRG) announced on January 24, 2017, a significant $2.0 billion accelerated share repurchase (ASR) program with Goldman, Sachs & Co. This ASR program is a key capital allocation decision by the company, indicating strong confidence in its financial position and future prospects. The company expects to fund this substantial repurchase using its existing cash and investments, signaling a robust balance sheet. The ASR program aims to reduce the number of outstanding shares, which can potentially enhance shareholder value through increased earnings per share and a higher stock price. While the exact number of shares repurchased will be determined by the volume-weighted average price over the repurchase period, the company will make an initial payment of $2.0 billion, with Goldman expected to deliver approximately 2.4 million shares shortly thereafter. The program is anticipated to conclude before the end of the fourth quarter of 2017, though it may be accelerated.

Key Highlights

  • 1Intuitive Surgical entered into a $2.0 billion accelerated share repurchase (ASR) program with Goldman, Sachs & Co.
  • 2The ASR program is expected to be completed by the end of Q4 2017, with potential for acceleration.
  • 3The company will make an initial payment of $2.0 billion and expects an initial delivery of approximately 2.4 million shares.
  • 4The total number of shares repurchased will be based on the daily volume-weighted average price less a discount.
  • 5The ASR program will be funded through existing cash and investments.
  • 6This ASR program utilizes a portion of the company's previously authorized stock repurchase program, with approximately $1.0 billion remaining under the original authorization.
  • 7The company also announced its financial results for the quarter ended December 31, 2016, via a press release furnished with this filing.

Frequently Asked Questions

The primary purpose of the accelerated share repurchase (ASR) program is to repurchase $2.0 billion of Intuitive Surgical's common stock from Goldman, Sachs & Co. This is a significant capital return to shareholders and indicates management's belief that the company's stock is undervalued or that it's an efficient use of capital.

The actual number of shares repurchased will be determined at the completion of the ASR program. It will generally be based on the daily volume-weighted average price per share of Intuitive's common stock during the repurchase period, less a discount. Goldman Sachs is expected to make an initial delivery of shares, and adjustments may be made at the conclusion of the program.

The company expects to fund the $2.0 billion ASR program through its existing cash and investments on hand. This indicates a strong liquidity position.

The ASR program is expected to be completed prior to the end of the fourth quarter of 2017. However, the completion date may be accelerated at Goldman Sachs' option during an acceleration period before the scheduled termination date.